{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:15:21Z","timestamp":1740104121798,"version":"3.37.3"},"reference-count":11,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Virol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1002\/jmv.24879","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T21:36:51Z","timestamp":1497562611000},"page":"1952-1957","source":"Crossref","is-referenced-by-count":5,"title":["Predictors of histological indication for treatment in HBeAg negative chronic HBV infection"],"prefix":"10.1002","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2047-8573","authenticated-orcid":false,"given":"Sener","family":"Barut","sequence":"first","affiliation":[{"name":"Faculty of Medicine; Department of Infectious Diseases and Clinical Microbiology; Gaziosmanpasa University; Tokat Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcmit","family":"Gemici","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Department of Infectious Diseases and Clinical Microbiology; Gaziosmanpasa University; Tokat Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdi","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Department of Infectious Diseases and Clinical Microbiology; Gaziosmanpasa University; Tokat Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Demir","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Department of Biostatistics; Gaziosmanpasa University; Tokat Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazilet","family":"Duygu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology; Ankara Onkology Training and Research Hospital; Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"10.1002\/jmv.24879-BIB0001|jmv24879-cit-0001","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"10.1002\/jmv.24879-BIB0002|jmv24879-cit-0002","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","article-title":"Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study","volume":"21","author":"Tozun","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/jmv.24879-BIB0003|jmv24879-cit-0003","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"American association for the study of liver diseases. AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1002\/jmv.24879-BIB0004|jmv24879-cit-0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"European association for the study of the liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1002\/jmv.24879-BIB0005|jmv24879-cit-0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1002\/jmv.24879-BIB0006|jmv24879-cit-0006","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Risk evaluation of viral load elevation and associated liver disease\/cancer-In HBV (the REVEAL-HBV) study group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.24879-BIB0007|jmv24879-cit-0007","unstructured":""},{"key":"10.1002\/jmv.24879-BIB0008|jmv24879-cit-0008","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.22518","article-title":"Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection","volume":"48","author":"Papatheodoridis","year":"2008","journal-title":"Hepatology"},{"key":"10.1002\/jmv.24879-BIB0009|jmv24879-cit-0009","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1111\/j.1365-2893.2011.01437.x","article-title":"Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B","volume":"18","author":"Sanai","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1002\/jmv.24879-BIB0010|jmv24879-cit-0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.24879-BIB0011|jmv24879-cit-0011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.09.007","article-title":"Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels","volume":"52","author":"Ormeci","year":"2016","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24879","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jmv.24879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T16:07:15Z","timestamp":1625328435000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1002\/jmv.24879","archive":["Portico"],"relation":{},"ISSN":["0146-6615"],"issn-type":[{"type":"print","value":"0146-6615"}],"subject":[],"published":{"date-parts":[[2017,7,17]]}}}